Trial tests Covid vaccine technology against a rare disease that affects babies
Preliminary study of messenger RNA therapy against propionic acidaemia shows it is safe, but doubts remain about its usefulness
Dwight Koeberl R Jude Samulski Gloria Gonz Duke University Hospital Institute For Rare Diseases Research University Of Navarre
Source: elpais.com